Transformation of pharmacists from general medicine to new specialty medicine

When it comes to cancer and tumor, most people stay away, because there are many patients whose lives have been quietly taken away From the data point of view, China is a big country of cancer and cancer, but the high incidence of digestive system cancer targeting drugs in China has been relatively scarce, and the road to cancer has been a long way to go The survival status of the majority of cancer patients in China is much worse than that in the United States If we use the value of "the number of deaths in that year / the number of new cases" to measure, the ratio of the top five tumors in China is higher than 50%, liver cancer is even close to 90%, while that of most tumors in the United States is lower than 50% This fully reflects the grim situation of anti-cancer in our country, and there is still a lot of work to be done to improve the survival rate and quality of life of cancer patients Moreover, from the number of patients, the top six cancers are lung cancer, gastric cancer, esophageal cancer, liver cancer, colorectal cancer and breast cancer, including digestive, digestive, and gastric cancers, which are far higher than the incidence rate of the United States and the world Now, the global preface of pharmaceutical companies, basically in the United States and Europe, and the United States as the world's largest drug consumer market, they have a positive correlation between the development direction of new drugs, and the incidence rate of diseases Later, with the emergence of immunosuppressants, it brings new hope to many patients with advanced cancer who are not able to use drugs In the pharmaceutical circle, it's basically a consensus that specialty drugs despise generic drugs Many practitioners of generic drugs hope to turn to the domain of specialty drugs when they apply for jobs, that is, they are interested in the domain of specialty drugs, the competitiveness of products and the concentration of customers The workplace is like a siege, inside and outside the city, mutual envy It's not necessarily that those who can do cancer drugs get a good pass ticket Many cancer drugs still can't reach the target due to various reasons beyond their personal ability In this case, their competitiveness in the human resource market will be affected However, from another point of view, cancer drug sales customers, relatively speaking, have relatively large positions If they can continue to accumulate and integrate resources in other areas of the industry, they can also better realize personal economic realization Many people will ask the author, now the overall environment is not good, how to combine their own customer resources, and constantly develop their own second curve? If you put the field in your own single field, you will inevitably have a narrow vision, but if you put it in the whole medical industry, when the customer resources are concentrated, developing the auxiliary resources from the point to the external, you will find many surprises I have a trainee before, who is a cancer product maker, but the other identity is the agent of gene detection Facing the same group of customers, it is of great significance to maximize the advantages and values of self in the region When this job is challenged by more and more external force majeure, how to keep accumulating wealth in economy has become the front-line sales that many regional managers fail to achieve now, so we have to start to focus on planning and arrangement Sometimes, the author often tells many fans that they should pay attention to the relationship with the immediate manager Many people ask the author that he is not a person who likes to communicate and has a lot of heart and eyes, which is always uncomfortable If you haven't reached the highest sky yet, don't be stingy and low headed.